• Kala Pharmaceuticals reports mixed late-stage study data for KPI-121 in dry eye disease; shares drop FirstWord Pharma Fri, 03 Oct 2025 04:36:54 GMT
• Kala Pharmaceuticals Faces Default Notice from Oxford Finance TipRanks Wed, 01 Oct 2025 12:37:11 GMT
• kala bio faces diminishing options after eye drug failure insights.citeline.com Tue, 30 Sep 2025 14:18:47 GMT
• united states shares higher at close of trade; dow jones industrial average up 0.15% Investing.com India Mon, 29 Sep 2025 20:43:16 GMT
• u.s. stocks higher at close of trade; dow jones industrial average up 0.15% Investing.com Mon, 29 Sep 2025 20:30:00 GMT
• Kala Bio Stock Just Plunged 89% Today – Here’s What Happened Stocktwits Mon, 29 Sep 2025 16:19:00 GMT
• KALA Stock Falls Sharply After KPI-012 Clinical Trial Disappointment GuruFocus Mon, 29 Sep 2025 16:14:29 GMT
• Kala Bio stock plunges after failed Phase 2b trial for eye treatment Investing.com Mon, 29 Sep 2025 15:49:48 GMT
• Kala Pharmaceuticals downgraded to Market Perform at LifeSci Capital TipRanks Mon, 29 Sep 2025 15:23:41 GMT
• Kala to cease development of KPI-012, evaluate strategic options TipRanks Mon, 29 Sep 2025 13:56:13 GMT
• KALA BIO plunges 92% after phase 2 failure of eye condition drug Seeking Alpha Mon, 29 Sep 2025 12:56:58 GMT
• Kala Pharmaceuticals Halts KPI-012 Development After Trial Failure TipRanks Mon, 29 Sep 2025 12:32:19 GMT
• strategic positioning and trial design propel kala pharmaceuticals to ‘buy’ rating TipRanks Thu, 18 Sep 2025 07:00:00 GMT
• Kala Pharmaceuticals price target raised to $35 from $12 at H.C. Wainwright TipRanks Wed, 17 Sep 2025 07:00:00 GMT
• analysts offer insights on healthcare companies: kala pharmaceuticals (kala) and milestone pharmaceuticals (mist) The Globe and Mail Tue, 16 Sep 2025 09:50:00 GMT
• kala pharmaceuticals price target raised to $33 from $15 at oppenheimer TipRanks Thu, 11 Sep 2025 07:00:00 GMT
• kala pharmaceuticals initiated with an outperform at mizuho TipRanks Mon, 08 Sep 2025 07:00:00 GMT
• rare eye disease biotech kala bio to present latest developments at h.c. wainwright conference Stock Titan Wed, 03 Sep 2025 07:00:00 GMT
• kala bio appoints todd bazemore as president, chief executive officer and director Stock Titan Tue, 02 Sep 2025 12:00:00 GMT
• Rare Disease Expert Todd Bazemore Takes Helm at KALA BIO Ahead of Crucial Phase 2b Trial Results Stock Titan Tue, 02 Sep 2025 07:00:00 GMT
• wall street analysts are bullish on top healthcare picks The Globe and Mail Thu, 14 Aug 2025 07:00:00 GMT
• optimistic buy rating for kala pharmaceuticals driven by kpi-012 trial prospects and financial viability TipRanks Wed, 13 Aug 2025 07:00:00 GMT
• kala bio reports q2 2025 earnings: eps -$1.82, revenue unavailable; focus on advancing kpi-012 for rare eye diseases. AInvest Mon, 11 Aug 2025 01:12:03 GMT
• kala bio reports q2 2025 earnings: eps -$1.82, revenue unavailable; focus on advancing kpi-012 for rare eye diseases. AInvest Sun, 10 Aug 2025 07:00:00 GMT
• suresh kashyap raised issue of paonta kala amb railway line which will benefit pharma industry himachalheadlines.com Thu, 31 Jul 2025 07:00:00 GMT
• Shimla MP Suresh Kashyap seeks rail line to connect pharma hub in Paonta Sahib and Kala Amb Times of India Wed, 30 Jul 2025 07:00:00 GMT
• acute ocular pain treatment market forecast to surge by 2034 as key pharma players drive therapeutic innovation delveinsight Menafn Tue, 29 Jul 2025 11:12:27 GMT
• blepharitis drugs market hits new high | major giants allergan (abbvie), novartis, bausch health newstrail.com Sat, 26 Jul 2025 15:57:34 GMT
• cdsco flags 55 substandard, 4 spurious drugs in june batch alert, full list inside Medical Dialogues Sat, 19 Jul 2025 07:00:00 GMT
• promising developments and market potential for kala pharmaceuticals’ kpi-012 amidst clinical and regulatory challenges TipRanks Sat, 12 Jul 2025 20:05:34 GMT
• kala pharmaceuticals (kala) receives buy rating from ladenburg | kala stock news GuruFocus Fri, 11 Jul 2025 11:01:22 GMT
• promising developments and market potential for kala pharmaceuticals’ kpi-012 amidst clinical and regulatory challenges TipRanks Fri, 11 Jul 2025 07:50:43 GMT
• FDA publishes drug rejection letters for 15 Massachusetts biotechs The Business Journals Thu, 10 Jul 2025 07:00:00 GMT
• promising developments and market potential for kala pharmaceuticals’ kpi-012 amidst clinical and regulatory challenges TipRanks Thu, 10 Jul 2025 07:00:00 GMT
• KALA BIO Eyes 100,000 Patient Market as Pivotal PCED Trial Completes Enrollment, Q3 Results Ahead Stock Titan Wed, 09 Jul 2025 07:00:00 GMT
• Kala Pharmaceuticals Completes Enrollment for Phase 2b Trial TipRanks Wed, 09 Jul 2025 07:00:00 GMT
• kala completes patient enrollment for chase phase 2 clinical trial TipRanks Wed, 09 Jul 2025 07:00:00 GMT
• top eye disease experts gather to reveal breakthrough pced treatment potential at kala bio kol event Stock Titan Mon, 07 Jul 2025 07:00:00 GMT
• moderate to severe acute pain market report 2034: epidemiology openPR.com Tue, 24 Jun 2025 19:52:00 GMT
• persistent epithelial defects clinical trials, companies, therapeutic assessment, emerging therapies, treatment algorithm, and pip... MenaFN Mon, 23 Jun 2025 11:10:18 GMT
• limbal stem cells deficiency market to expand significantly by 2034, states delveinsight report kala pharma, clips bnc co., rheace... MENAFN.com Tue, 10 Jun 2025 07:06:29 GMT
• palantir vs. snowflake: which ai stock could soar in 5 years? The Globe and Mail Fri, 06 Jun 2025 13:29:00 GMT
• kala pharmaceuticals assumed with an outperform at oppenheimer TipRanks Tue, 03 Jun 2025 04:46:15 GMT
• kala stock gains momentum with oppenheimer's positive outlook | kala stock news GuruFocus Mon, 02 Jun 2025 07:00:00 GMT
• kala pharmaceuticals assumed with an outperform at oppenheimer TipRanks Mon, 02 Jun 2025 07:00:00 GMT
• alcon gains first fda prescription drug nod since novartis split, scoring with drops for dry eye disease Fierce Pharma Thu, 29 May 2025 07:00:00 GMT
• kala bio to present at jefferies global healthcare conference GlobeNewswire Thu, 29 May 2025 07:00:00 GMT
• kala bio to reveal latest eye disease pipeline progress at major jefferies healthcare conference Stock Titan Thu, 29 May 2025 07:00:00 GMT
• kala bio stock target cut to $12 by h.c. wainwright, retains buy Investing.com Sat, 24 May 2025 07:00:00 GMT
• kala pharmaceuticals price target lowered to $12 from $15 at h.c. wainwright TipRanks Fri, 23 May 2025 11:36:29 GMT
• kala price target reduced by h.c. wainwright after q3 results | kala stock news GuruFocus Fri, 23 May 2025 07:00:00 GMT
• best healthcare stocks: eli lilly vs. novo nordisk The Globe and Mail Wed, 21 May 2025 07:00:00 GMT
• kala focuses on advancing kpi-012 development amid pivotal trials | kala stock news GuruFocus Wed, 14 May 2025 13:31:19 GMT
• kala pharmaceuticals reports q1 eps ($1.41) vs ($4.20) last year TipRanks Wed, 14 May 2025 12:41:16 GMT
• kala's pced drug could reach 100,000 patients - q3 trial results coming Stock Titan Wed, 14 May 2025 12:00:00 GMT
• kala bio reports first quarter 2025 financial results and provides corporate update GlobeNewswire Wed, 14 May 2025 07:00:00 GMT
• biodurable ophthalmic drug delivery system market is set to experience a revolutionary growth openPR.com Fri, 09 May 2025 07:00:00 GMT
• blepharitis treatment market 2034: ema, pdma, fda approval, clinical trials, medication, prevalence, nice approval, revenue, stati... Barchart.com Mon, 28 Apr 2025 11:00:00 GMT
• government & technical consulting stocks q4 earnings: ul solutions (nyse:uls) best of the bunch The Globe and Mail Mon, 28 Apr 2025 07:00:00 GMT
• how the (kala) price action is used to our advantage news.stocktradersdaily.com Mon, 21 Apr 2025 08:28:00 GMT
• bombardier inc stock analysis: what to know before q1 2025 results The Globe and Mail Tue, 15 Apr 2025 07:00:00 GMT
• oppenheimer maintains kala bio stock outperform with $15 target by investing.com Investing.com India Mon, 14 Apr 2025 07:00:00 GMT
• kala stock touches 52-week low at $3.4 amid market challenges Investing.com India Sat, 12 Apr 2025 00:13:53 GMT
• kala pharmaceuticals announces executive retention agreements TipRanks Fri, 11 Apr 2025 07:00:00 GMT
• kala stock touches 52-week low at $3.4 amid market challenges Investing.com UK Fri, 11 Apr 2025 07:00:00 GMT
• samuel crossan of jll to speak at boston life sciences conference Boston Real Estate Times Thu, 10 Apr 2025 07:00:00 GMT
• kala pharmaceuticals announces executive retention agreements TipRanks Thu, 10 Apr 2025 07:00:00 GMT
• kala pharmaceuticals: promising clinical developments and financial stability support buy rating TipRanks Fri, 04 Apr 2025 11:03:32 GMT
• h.c. wainwright maintains buy on kala bio, target at $15 Investing.com Fri, 04 Apr 2025 07:00:00 GMT
• oppenheimer maintains outperform on kala pharmaceuticals stock Investing.com Tue, 01 Apr 2025 07:00:00 GMT
• kala pharmaceuticals reports q4 eps ($1.74) vs. ($3.18) last year TipRanks Tue, 01 Apr 2025 01:57:45 GMT
• kala bio reports fourth quarter and full year 2024 financial results and provides corporate update GlobeNewswire Mon, 31 Mar 2025 07:00:00 GMT
• kala bio secures 2-year cash runway as phase 2b trial hits 87 patient milestone Stock Titan Mon, 31 Mar 2025 07:00:00 GMT
• drug alert: 47 drug samples fail to clear cdsco test, 1 declared spurious Medical Dialogues Mon, 31 Mar 2025 07:00:00 GMT
• (kala) pivots trading plans and risk controls news.stocktradersdaily.com Sat, 15 Mar 2025 05:38:00 GMT
• cyclosporine 0.09% improved dry eye signs in patients previously treated with 0.05% Healio Tue, 11 Mar 2025 07:00:00 GMT
• kala bio to present at td cowen 45th annual health care conference StockTitan Wed, 26 Feb 2025 13:00:00 GMT
• what will kala bio reveal at the td cowen healthcare conference next week? Stock Titan Wed, 26 Feb 2025 08:00:00 GMT
• trading (kala) with integrated risk controls news.stocktradersdaily.com Fri, 21 Feb 2025 08:00:00 GMT
• india develops new drug to tackle burden of kala-azar, antibiotic to fight amr OTV News Fri, 21 Feb 2025 08:00:00 GMT
• acute ocular pain drugs market 2034: ema, pdma, fda approvals, openPR Tue, 18 Feb 2025 08:00:00 GMT
• david schenkein resigns from agios’ board; moderna hires roivant exec as chief marketing officer Endpoints News Fri, 14 Feb 2025 08:00:00 GMT
• amd is a top artificial intelligence (ai) stock to buy after its recent earnings The Globe and Mail Fri, 14 Feb 2025 08:00:00 GMT
• kala bio appoints new interim ceo amid leadership shuffle by investing.com Investing.com Canada Thu, 13 Feb 2025 00:18:13 GMT
• kala bio, inc. announces chief executive officer changes -february 12, 2025 at 08:00 am est Marketscreener.com Wed, 12 Feb 2025 14:56:38 GMT
• leadership shake-up at kala bio: new ceo takes helm before crucial phase 2b eye treatment results Stock Titan Wed, 12 Feb 2025 08:00:00 GMT
• kala bio appoints new interim ceo amid leadership shuffle Investing.com Wed, 12 Feb 2025 08:00:00 GMT
• kala bio announces ceo departure, appoints interim leader Investing.com Wed, 12 Feb 2025 08:00:00 GMT
• kala bio chief executive mark iwicki resigns; shares fall -february 12, 2025 at 11:59 am est Marketscreener.com Wed, 12 Feb 2025 08:00:00 GMT
• dollar gains and gold rallies to a record high on us tariffs The Globe and Mail Mon, 10 Feb 2025 08:00:00 GMT
• kala khatta, paan, jasmine: condom flavours india prefers to use, as per manforce Mint Wed, 29 Jan 2025 08:00:00 GMT
• kala stock soars to 52-week high, reaching $8.81 by investing.com Investing.com Australia Wed, 29 Jan 2025 02:29:33 GMT
• kala stock soars to 52-week high, reaching $8.81 by investing.com Investing.com UK Tue, 28 Jan 2025 21:02:00 GMT
• ED attaches assets worth Rs 80 crore in money laundering case against pharma company India Today Mon, 27 Jan 2025 08:00:00 GMT
• acute ocular pain market growth to accelerate in forecast period openPR Fri, 24 Jan 2025 15:18:00 GMT
• ocular inflammation and pain market expected to experience major growth by 2032, according to delveinsight EIN News Tue, 21 Jan 2025 08:00:00 GMT
• brookfield renewable partners lp (bep-un-t) quote - press release The Globe and Mail Fri, 17 Jan 2025 14:31:11 GMT
• topical drugs market trends analysis report 2025-2030, with GlobeNewswire Fri, 17 Jan 2025 08:00:00 GMT
• live nation entertainment (lyv-n) quote - press release The Globe and Mail Mon, 13 Jan 2025 08:00:00 GMT
• kala bio executive todd bazemore sells $15,206 in stock by investing.com Investing.com Canada Wed, 08 Jan 2025 05:12:27 GMT
• kala bio cfo mary reumuth sells $13,016 in company stock Investing.com Wed, 08 Jan 2025 01:46:46 GMT
• kala bio's chief business officer sells $15,420 in stock Investing.com Wed, 08 Jan 2025 01:46:45 GMT
• kala bio's chief business officer sells $15,420 in stock Investing.com Tue, 07 Jan 2025 08:00:00 GMT
• kala bio cfo mary reumuth sells $13,016 in company stock Investing.com Tue, 07 Jan 2025 08:00:00 GMT
• kala bio executive todd bazemore sells $15,206 in stock Investing.com Tue, 07 Jan 2025 08:00:00 GMT
• kala bio ceo mark iwicki sells $44,093 in stock by investing.com Investing.com Canada Tue, 07 Jan 2025 08:00:00 GMT
• baker bros. advisors buys $2 million in kala bio shares by investing.com Investing.com Australia Wed, 01 Jan 2025 08:00:00 GMT
• Baker Bros. Advisors buys $2 million in Kala Bio shares Investing.com Tue, 31 Dec 2024 08:00:00 GMT
• bank of nova scotia (bns-n) quote - press release The Globe and Mail Fri, 13 Dec 2024 08:00:00 GMT
• himachal’s pharma industry under scrutiny: 38 medicines fail quality tests, stocks recalled himachal headlines Thu, 28 Nov 2024 08:00:00 GMT
• kala bio to present at piper sandler healthcare conference, showcasing eye disease pipeline StockTitan Wed, 27 Nov 2024 08:00:00 GMT
• ophthalmic drug delivery systems market is likely to experience a tremendous growth in near future openPR Tue, 26 Nov 2024 08:00:00 GMT
• kala pharmaceuticals announces ind submission of its mpp-formulated loteprednol etonbonate (le-mpp) for post-cataract surgery Marketscreener.com Sun, 24 Nov 2024 14:28:04 GMT
• kala pharmaceuticals retains stock target with buy rating on trial progress Investing.com Tue, 19 Nov 2024 05:18:42 GMT
• kala pharmaceuticals retains stock target with buy rating on trial progress Investing.com Mon, 18 Nov 2024 08:00:00 GMT
• opawica explorations inc (opw-x) quote - press release The Globe and Mail Fri, 15 Nov 2024 12:56:15 GMT
• opawica explorations inc (opwef) quote - press release The Globe and Mail Fri, 15 Nov 2024 12:56:15 GMT
• tsx global base metals ew index (txbe) quote - press release The Globe and Mail Fri, 15 Nov 2024 08:00:00 GMT
• kala bio, inc. reports earnings results for the third quarter and nine months ended september 30, 2024 Marketscreener.com Wed, 13 Nov 2024 17:45:59 GMT
• kala bio reports third quarter 2024 financial results and provides corporate update Yahoo Finance Tue, 12 Nov 2024 08:00:00 GMT
• kala pharmaceuticals reports q3 eps ($1.93) vs ($3.41) last year TipRanks Tue, 12 Nov 2024 08:00:00 GMT
• tsx canadian dividend aristocrats index (txdv) quote - press release The Globe and Mail Tue, 12 Nov 2024 08:00:00 GMT
• tsx composite weight index (txce) quote - press release The Globe and Mail Mon, 11 Nov 2024 08:00:00 GMT
• persistent corneal epithelial defects pipeline 2024: clinical openPR Tue, 29 Oct 2024 20:22:00 GMT
• global persistent epithelial defect management market set to surge to usd 44.49 billion by 2033 at a 18% of cagr PharmiWeb.com Tue, 29 Oct 2024 07:00:00 GMT
• intuitive machines inc (lunr-q) quote - press release The Globe and Mail Mon, 28 Oct 2024 07:00:00 GMT
• limbal stem cells deficiency market on track for major expansion openPR Mon, 28 Oct 2024 07:00:00 GMT
• 49 drugs samples including pan 40, calvam 625, zerodol-sp tablet fail to meet cdsco quality test Medical Dialogues Mon, 28 Oct 2024 07:00:00 GMT
• ed raids in mumbai, haryana against pharma company in rs 220-crore fraud case India Today Sat, 26 Oct 2024 07:00:00 GMT
• 23 medicines, including cancer and heart drugs, fail quality standards himachal headlines Fri, 25 Oct 2024 07:00:00 GMT
• ed searches 8 locations in mumbai, haryana in rs 220-cr bank fraud case against pharma company The Indian Express Fri, 25 Oct 2024 07:00:00 GMT
• neuropathic ocular pain market to rise by 2034 | novartis ag, openPR Wed, 16 Oct 2024 07:00:00 GMT
• sudden eye pain relief treatment market size & share 2024|segmentation overview 2032 WICZ Thu, 03 Oct 2024 07:00:00 GMT
• ocular drug delivery global market advancements highlighted by size, share, trends, forecast to 2033 WhaTech Wed, 25 Sep 2024 07:00:00 GMT
• global ophthalmic drugs market insights discussed regarding drivers and growth 2024 WhaTech Mon, 23 Sep 2024 12:30:47 GMT
• oppenheimer ‘encouraged’ by kala pharmaceuticals trial progress TipRanks Mon, 19 Aug 2024 07:00:00 GMT
• kala bio (nasdaq:kala) and urogen pharma (nasdaq:urgn) financial contrast Defense World Sat, 10 Aug 2024 19:25:17 GMT
• kala pharmaceuticals stock target cut by h.c. wainwright, retains buy rating Investing.com Wed, 07 Aug 2024 15:32:10 GMT
• kala pharmaceuticals reports q2 eps ($3.16) vs ($4.36) last year TipRanks Tue, 06 Aug 2024 12:00:00 GMT
• kala bio reports second quarter 2024 financial results and provides corporate update Yahoo Finance Tue, 06 Aug 2024 07:00:00 GMT
• himachal pradesh suspends licence of two pharma companies Tribune India Sun, 04 Aug 2024 23:05:16 GMT
• loteprednol etabonate market is expected to reach at a cagr of 9.40% | bausch + lomb (valeant), kala pharmaceuticals, ak – knowcas... KnowCasino Tue, 30 Jul 2024 17:44:11 GMT
• thyroid eye treatment market growth and opportunity up to[ 2024- 2032] WICZ Tue, 30 Jul 2024 10:21:00 GMT
• tramadol seizure: clean chit to kala amb pharma firm owner raises eyebrows drugscontrol.org Sun, 21 Jul 2024 10:58:53 GMT
• nasdaq 100 index, price chart today live, forecast, futures InvestingCube Wed, 17 Jul 2024 16:21:32 GMT
• ocular neuropathic pain market to witness significant incremental opportunity through 2024-2031 | okyo pharma, ocular therapeutix,... TIMC Mon, 15 Jul 2024 16:49:36 GMT
• layoff tracker: io biotech, kala halve headcount amid pipeline problems BioSpace Mon, 15 Jul 2024 11:09:48 GMT
• kala pharma sees ipo of 6 mln shares priced between $14-$16/shr Reuters Wed, 10 Jul 2024 07:00:00 GMT
• kala pharmaceuticals | biotechnology | the pharmaletter The Pharma Letter Tue, 02 Jul 2024 07:00:00 GMT
• Kala Pharmaceuticals | Biotechnology | The Pharmaletter The Pharma Letter Mon, 01 Jul 2024 01:46:52 GMT
• kala bio executive sells shares worth over $26,000 Investing.com India Fri, 28 Jun 2024 07:00:00 GMT
• bank of america executives trade gabelli utility trust shares worth over $6,000 by investing.com Investing.com Fri, 28 Jun 2024 06:07:26 GMT
• kala bio secures $12.5 million in private placement by investing.com Investing.com Fri, 28 Jun 2024 05:49:45 GMT
• palo alto networks director mccarthy sells over $312k in company stock by investing.com Investing.com India Fri, 28 Jun 2024 03:17:37 GMT
• kala pharmaceuticals (kala) crossed above the 50-day moving average: what that means for investors Yahoo New Zealand News Fri, 28 Jun 2024 01:26:00 GMT
• how much of kala pharmaceuticals, inc. (nasdaq:kala) do institutions own? Yahoo New Zealand News Fri, 28 Jun 2024 01:26:00 GMT
• cathie wood's ark etf focuses on pagerduty, 10x genomics stock by investing.com Investing.com Fri, 28 Jun 2024 01:08:18 GMT
• gauzy stock gets 'buy' from stifel, projects significant revenue growth by investing.com Investing.com Fri, 28 Jun 2024 01:08:18 GMT
Kala Pharmaceuticals, Inc(NASDAQ:KALA) 
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye diseases. The company's product candidates include EYSUVIS...
Website: http://www.kalarx.com
Founded: 2009
Full Time Employees: 136
Sector: Healthcare
Industry: Biotechnology